MedTrace Logo

Cognitive and Self-regulatory Mechanisms Of Obesity Study

NCT02786238 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2021-01-27

No results posted yet for this study

Summary

This study will be the first clinical trial to examine the impact of two different weight loss interventions on novel mechanisms that promote obesity and impede its successful treatment, including cognitive function and self-regulatory factors. The results will provide important data about how impaired cognitive function and/or self-regulation promote obesity and how different weight loss treatments may differentially impact these factors; this information will be used to identify promising cognitive and self-regulatory treatment targets for preventing further obesity development and for maintaining weight loss.

Conditions

Interventions

BEHAVIORAL

Standard Behavioral Treatment (SBT)

See description of treatment arm.

BEHAVIORAL

Acceptance-Based Treatment (ABT)

See description of treatment arm. \*\*Cherokee Nation members receive only the ABT intervention as they are in an open, feasibility trial and are not randomized.\*\*

Sponsors & Collaborators

  • Kent State University

    collaborator OTHER

  • Case Western Reserve University

    collaborator OTHER

  • University of Minnesota

    collaborator OTHER

  • Drexel University

    collaborator OTHER

  • University of Oklahoma

    collaborator OTHER

  • Cherokee Nation

    collaborator UNKNOWN

  • Oklahoma State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-10-31
Completion
2020-08-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786238 on ClinicalTrials.gov